{"nctId":"NCT00124982","briefTitle":"Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy","startDateStruct":{"date":"2005-04"},"conditions":["Rheumatoid Arthritis"],"count":1286,"armGroups":[{"label":"Open-label Abatacept (ABA)-Previous User","type":"EXPERIMENTAL","interventionNames":["Drug: Abatacept","Drug: Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)"]},{"label":"Open-label ABA-Current User","type":"EXPERIMENTAL","interventionNames":["Drug: Abatacept","Drug: Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)","Drug: Anti-Tumor Necrosing Factor (TNF) Therapy"]},{"label":"Long-term ABA","type":"EXPERIMENTAL","interventionNames":["Drug: Abatacept","Drug: Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)"]}],"interventions":[{"name":"Abatacept","otherNames":["Orencia"]},{"name":"Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)","otherNames":[]},{"name":"Anti-Tumor Necrosing Factor (TNF) Therapy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Completed double-blind portion of the IM101064 study.\n* Rheumatoid arthritis (RA) for greater than 1 year from the time of initial diagnosis\n* American College of Rheumatology (ACR) functional class I, II, III\n* Subjects currently or previously received an anti-TNF therapy at an approved labeled dose for at least 3 months\n\nExclusion Criteria:\n\n* Subjects with active vasculitis of a major organ system (except subcutaneous rheumatoid nodules)\n* History of cancer within the last 5 years (other than non-melanoma skin cell cancers cured by local resection)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Death, Serious Adverse Events (SAEs), Related SAEs, SAEs Leading to Discontinuations, AEs, Related AEs, or AEs Leading to Discontinuations","description":"AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with treatment.SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event.Related AE/SAE=Certain,Probable,Possible,or Missing relationship to Drug","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"350","spread":null},{"groupId":"OG001","value":"473","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"190","spread":null},{"groupId":"OG001","value":"273","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With AEs of Special Interest","description":"AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. AEs of special interest are those AEs that may be associated with the use of immunomodulatory drugs, including all infections, serious infections, and opportunistic infections; autoimmune disorders; neoplasms; acute infusional AEs (pre-specified AEs occurring within 1 hour of start of infusion) and peri-infusional AEs (pre-specified AEs occurring within 24 hours of the start of infusion).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57","spread":null},{"groupId":"OG001","value":"99","spread":null}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Number of Participants With Clinically Meaningful Improvement (CMI) in Disease Activity Score (DAS 28), Low Disease Activity (LDAS), or Remission at Day 169","description":"The DAS 28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). A clinically significant response= decrease in DAS28 score of \\>1.2 from baseline.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"267","spread":null},{"groupId":"OG001","value":"320","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"133","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"82","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Hematology Laboratories Meeting Marked Abnormality (MA) Criteria","description":"Upper Normal Limit (ULN), Lower Normal Limit (LLN), Baseline (BL). Marked abnormality criteria are: Hemoglobin (HGB): \\>3 g/dL decrease from BL; Hematocrit: \\<0.75 \\* BL; Erythrocytes: \\<0.75 \\* BL; Platelets (PLT): \\<0.67 \\* LLN/\\>1.5 \\* ULN, or if BL \\< LLN then use 0.5 \\* BL/\\<100,000 mm\\^3; Leukocytes: \\<0.75 \\* LLN/ \\>1.25 \\* ULN, or if BL\\<LLN then use \\<0.8 \\* BL/\\>ULN, or if BL\\>ULN then use \\>1.2 \\* BL/\\<LLN; neutrophils+bands: \\<1.0 \\* 10\\^3 c/uL; eosinophils: \\>0.750 \\* 10\\^3 c/uL; basophils: \\> 400 mm\\^3; monocytes: \\>2000 mm\\^3; lymphocytes: \\<0.750 \\* 10\\^3 c/uL/ \\>7.50 \\* 10\\^3 c/uL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Liver and Kidney Function Laboratories Meeting MA Criteria","description":"Marked abnormality criteria: Alkaline phosphatase (ALP): \\>2\\* ULN, or if BL\\>ULN then use \\>3\\* BL; aspartate aminotransferase (AST): \\>3\\* ULN, or if BL\\>ULN then use \\>4\\* BL; alanine aminotransferase (ALT): \\>3\\* ULN, or if BL\\>ULN then use \\>4\\* BL; G-Glutamyl transferase (GGT): \\>2\\* ULN, or if BL\\>ULN then use \\>3\\* BL; Bilirubin: \\>2\\* ULN, or if BL\\>ULN then use \\>4\\* BL; blood urea nitrogen (BUN): \\>2\\* BL; creatinine: \\>1.5\\* BL","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Electrolyte Laboratories Meeting MA Criteria","description":"Marked abnormality criteria:Sodium (Na): \\<0.95\\* LLN/ \\>1.05\\* ULN,or if BL\\<LLN then use 0.95\\* BL or \\>ULN,or if BL\\>ULN then use\\>1.05\\* BL or \\<LLN; potassium (K): \\<0.9\\* LLN/\\>1.1\\* ULN,or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN; chloride: \\<0.9\\* LLN/\\>1.1\\* ULN, or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN; calcium (Ca): \\<0.8\\* LLN/\\>1.2\\* ULN, or if BL\\<LLN then use 0.75\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.25\\* BL or \\<LLN; phosphorous (P): \\<0.75\\* LLN/ \\>1.25\\* ULN, or if BL\\<LLN then use 0.67\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.33\\* BL or \\<LLN","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Other Chemistry and Urinalysis Laboratories Meeting MA Criteria","description":"Marked abnormality criteria: serum glucose (Glu):\\<65 mg/dL/ \\>220 mg/dL; fasting serum Glu: \\<0.8\\* LLN/\\>1.5\\* ULN, or if BL\\<LLN then use 0.8\\* BL or \\>ULN, or if BL\\>ULN then use \\>2.0\\* BL or \\<LLN; total protein: \\<0.9\\* LLN/\\>1.1\\* ULN; albumin: \\<0.9\\* LLN,or if BL\\<LLN then use \\<0.75 BL; uric acid: \\>1.5\\* ULN, or if BL\\>ULN then use \\>2\\* BL. Urinalysis (Urine protein, urine Glu, urine blood, leukocyte esterase, Red Blood Cells \\[RBCs\\], White Blood Cells \\[WBCs\\]):Use ≥2 when BL value missing or value ≥4,or when pre-dose=0 or 0.5. Use ≥3 when pre-dose=1. Use ≥4 when pre-dose=2 or 3","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]}]},{"type":"PRIMARY","title":"Short-term Period: Mean Change From Baseline in Systolic and Diastolic Blood Pressure","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[]},{"type":"PRIMARY","title":"Short-term Period: Number of Participants With Positive Anti-Abatacept or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Responses by Enzyme-Linked Immunosorbant Assay (ELISA)","description":"Serum samples from all treated adult participants with active rheumatoid arthritis (RA) were screened for the presence of drug-specific antibodies using ELISA. Immunogenicity was defined as the presence of a positive anti-abatacept or anti-CTLA4 antibody.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Time-matched Baseline (Day 0) DAS 28 and DAS 28 for Post-Baseline Visits Through 6 Month Open-Label","description":"The DAS 28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). Time-matched baseline (Day 0) values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.21","spread":"0.73"},{"groupId":"OG001","value":"6.17","spread":"0.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.46","spread":"1.05"},{"groupId":"OG001","value":"5.49","spread":"1.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.22","spread":"0.72"},{"groupId":"OG001","value":"6.17","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.05","spread":"1.20"},{"groupId":"OG001","value":"5.09","spread":"1.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.22","spread":"0.74"},{"groupId":"OG001","value":"6.16","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.65","spread":"1.27"},{"groupId":"OG001","value":"4.72","spread":"1.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.21","spread":"0.73"},{"groupId":"OG001","value":"6.16","spread":"0.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.44","spread":"1.37"},{"groupId":"OG001","value":"4.57","spread":"1.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.20","spread":"0.73"},{"groupId":"OG001","value":"6.15","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.24","spread":"1.36"},{"groupId":"OG001","value":"4.39","spread":"1.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.19","spread":"0.74"},{"groupId":"OG001","value":"6.16","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.19","spread":"1.38"},{"groupId":"OG001","value":"4.27","spread":"1.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.19","spread":"0.73"},{"groupId":"OG001","value":"6.15","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.16","spread":"1.43"},{"groupId":"OG001","value":"4.14","spread":"1.47"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Time-matched Change From Baseline (Day 0) in DAS 28 Through 6 Month Open-Label","description":"The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). Time-matched mean change from BL= Post-BL value - time-matched BL value, where the time-matched BL value represents the mean BL (Day 0) value for only that cohort of participants with measurements available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.75","spread":"0.04"},{"groupId":"OG001","value":"-0.68","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":"0.05"},{"groupId":"OG001","value":"-1.07","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.57","spread":"0.06"},{"groupId":"OG001","value":"-1.44","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.76","spread":"0.06"},{"groupId":"OG001","value":"-1.60","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.96","spread":"0.07"},{"groupId":"OG001","value":"-1.76","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.00","spread":"0.07"},{"groupId":"OG001","value":"-1.90","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.02","spread":"0.07"},{"groupId":"OG001","value":"-2.01","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Change From Baseline to Day 169 in High Sensitivity C-Reactive Protein (Hs-CRP)","description":"hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.88","spread":"0.13"},{"groupId":"OG001","value":"-0.68","spread":"0.13"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Change From Baseline to Day 169 in Rheumatoid Factor (RF)","description":"RF is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-32.2","spread":"11.33"},{"groupId":"OG001","value":"-22.8","spread":"10.19"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Change From Baseline to Day 169 in the Health Assessment Questionnaire Disability Index (HAQ-DI)","description":"The HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.34","spread":"0.03"},{"groupId":"OG001","value":"-0.41","spread":"0.03"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Number of Participants Achieving a Clinically Meaningful HAQ Response","description":"HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do). Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"208","spread":null},{"groupId":"OG001","value":"281","spread":null}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Baseline Short Form 36 (SF-36) Quality of Life Physical Component Summary (PCS), Mental Component Summary (MCS), and SF-36 Individual Component Scores","description":"The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score. Change from Baseline= post-Baseline - Baseline value.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.81","spread":"7.74"},{"groupId":"OG001","value":"28.75","spread":"7.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.45","spread":"12.98"},{"groupId":"OG001","value":"42.43","spread":"12.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27.72","spread":"9.87"},{"groupId":"OG001","value":"28.22","spread":"9.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.06","spread":"7.95"},{"groupId":"OG001","value":"31.38","spread":"7.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.73","spread":"7.17"},{"groupId":"OG001","value":"31.13","spread":"7.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.70","spread":"9.40"},{"groupId":"OG001","value":"35.71","spread":"9.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.95","spread":"9.21"},{"groupId":"OG001","value":"36.62","spread":"9.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.76","spread":"11.86"},{"groupId":"OG001","value":"34.13","spread":"10.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.21","spread":"13.99"},{"groupId":"OG001","value":"36.98","spread":"14.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.79","spread":"12.79"},{"groupId":"OG001","value":"41.92","spread":"11.95"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With Death, Serious Adverse Events (SAEs), Related SAEs, SAEs Leading to Discontinuations, AEs, Related AEs, or AEs Leading to Discontinuations","description":"AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with treatment.SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event.Related AE/SAE=Certain,Probable,Possible,or Missing relationship to Drug","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"328","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With AEs of Special Interest","description":"AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. AEs of special interest are those AEs that may be associated with the use of immunomodulatory drugs, including all infections, serious infections, and opportunistic infections; autoimmune disorders; neoplasms; acute infusional AEs (pre-specified AEs occurring within 1 hour of start of infusion) and peri-infusional AEs (pre-specified AEs occurring within 24 hours of the start of infusion).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"177","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With Hematology Laboratories Meeting Marked Abnormality (MA) Criteria","description":"ULN=upper limit of normal; LLN=lower limit of normal; BL=baseline. Marked abnormality criteria=Hemoglobin: \\>3 g/dL decrease from BL; Hematocrit: \\<0.75\\*BL; Erythrocytes:\\<0.75\\*BL; Platelets: \\<0.67\\*LLN/\\>1.5 \\* ULN, or if BL\\<LLN, use 0.5\\*BL/\\<100,000 mm\\^3; Leukocytes: \\<0.75\\*LLN/\\>1.25\\*ULN, or if BL\\<LLN, use \\<0.8\\*BL/\\>ULN, or if BL\\>ULN,use \\>1.2\\*BL/\\<LLN; neutrophils+bands: \\<1.0\\*10\\^3 c/uL; eosinophils: \\>0.750\\*10\\^3 c/uL; basophils: \\>400 mm\\^3; monocytes: \\>2000 mm\\^3; lymphocytes: \\<0.750\\*10\\^3 c/uL/\\>7.50\\*10\\^3 c/uL.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With Liver and Kidney Function Laboratories Meeting MA Criteria","description":"Marked abnormality criteria: Alkaline phosphatase (ALP): \\>2\\*ULN, or if BL\\>ULN, use \\>3\\*BL; aspartate aminotransferase (AST): \\>3\\*ULN, or if BL\\>ULN,use \\>4\\*BL; alanine aminotransferase (ALT): \\>3\\*ULN, or if BL\\>ULN, use \\>4\\*BL; G-Glutamyl transferase (GGT): \\>2\\*ULN, or if BL\\>ULN, use \\>3\\*BL; bilirubin: \\>2\\*ULN, or if BL\\>ULN, use \\>4\\*BL; blood urea nitrogen (BUN): \\>2\\*BL; creatinine: \\>1.5\\*BL","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With Electrolyte Laboratories Meeting MA Criteria","description":"Marked abnormality criteria:Sodium (Na): \\<0.95\\* LLN/ \\>1.05\\* ULN,or if BL\\<LLN then use 0.95\\* BL or \\>ULN,or if BL\\>ULN then use\\>1.05\\* BL or \\<LLN; potassium (K): \\<0.9\\* LLN/\\>1.1\\* ULN,or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN; chloride: \\<0.9\\* LLN/\\>1.1\\* ULN, or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN; calcium (Ca): \\<0.8\\* LLN/\\>1.2\\* ULN, or if BL\\<LLN then use 0.75\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.25\\* BL or \\<LLN; phosphorous (P): \\<0.75\\* LLN/ \\>1.25\\* ULN, or if BL\\<LLN then use 0.67\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.33\\* BL or \\<LLN","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Number of Participants With Other Chemistry and Urinalysis Laboratories Meeting MA Criteria","description":"Marked abnormality criteria: serum glucose (Glu):\\<65 mg/dL/ \\>220 mg/dL; fasting serum Glu: \\<0.8\\* LLN/\\>1.5\\* ULN, or if BL\\<LLN then use 0.8\\* BL or \\>ULN, or if BL\\>ULN then use \\>2.0\\* BL or \\<LLN; total protein: \\<0.9\\* LLN/\\>1.1\\* ULN; albumin: \\<0.9\\* LLN,or if BL\\<LLN then use \\<0.75 BL; uric acid: \\>1.5\\* ULN, or if BL\\>ULN then use \\>2\\* BL. Urinalysis (Urine protein, urine Glu, urine blood, leukocyte esterase, Red Blood Cells \\[RBCs\\], White Blood Cells \\[WBCs\\]):Use ≥2 when BL value missing or value ≥4,or when pre-dose=0 or 0.5. Use ≥3 when pre-dose=1. Use ≥4 when pre-dose=2 or 3","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Hemoglobin (HGB), Total Protein, and Albumin Over Time","description":"HGB normal range (NR)=11.6 - 16.2 g/dL, marked abnormality (MA) is \\>3 g/dL decrease from BL. Total protein NR=6.0 - 8.4 g/dL, MA is \\<0.9\\* LLN/\\>1.1\\* ULN; Albumin NR=3.5 - 5.3 g/dL, MA is \\<0.9\\* LLN, or if BL\\<LLN then use \\<0.75 BL","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.22","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.13","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.47","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.16","spread":"0.04"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Hematocrit Over Time","description":"The hematocrit value refers to the percentage of blood volume that is occupied by red blood cells. Hematocrit values for participants were expressed as percentages and were averaged to yield a group mean value (percentage) at a particular time point. The mean change from baseline in hematocrit value (expressed as a percent)= mean post-baseline value (expressed as a percent) - mean baseline value (expressed as a percent).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.00","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Erythrocytes Over Time","description":"Erythrocytes NR= 3.80 - 5.50 \\*10\\^6 c/uL, MA is \\<0.75 \\* BL","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"0.04"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Platelets (PLT) Over Time","description":"Erythrocytes NR= 3.80 - 5.50 \\*10\\^6 c/uL, MA is \\<0.75 \\* BL","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.2","spread":"6.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-67.7","spread":"11.02"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in White Blood Cells Over Time","description":"Leukocytes NR=4.1 - 12.3\\*10\\^3 c/uL, MA is \\<0.75 \\* LLN/ \\>1.25 \\* ULN, or if BL\\<LLN then use \\<0.8 \\* BL/\\>ULN, or if BL\\>ULN then use \\>1.2 \\* BL/\\<LLN. Neutrophils+bands MA is \\<1.0 \\* 10\\^3 c/uL. Eosinophils MA is \\>0.750 \\* 10\\^3 c/uL. Basophils MA is \\> 400 mm\\^3. Monocytes MA is \\>2000 mm\\^3. Lymphocytes MA is \\<0.750 \\* 10\\^3 c/uL/ \\>7.50 \\* 10\\^3 c/uL","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.86","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.83","spread":"0.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.08","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.49","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.56","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.10","spread":"0.09"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Alkaline Phosphatase (ALP), Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), and G-Glutamyl Transferase (GGT) Over Time","description":"HGB normal range (NR)=11.6 - 16.2 g/dL, marked abnormality (MA) is \\>3 g/dL decrease from BL. Total protein NR=6.0 - 8.4 g/dL, MA is \\<0.9\\* LLN/\\>1.1\\* ULN; Albumin NR=3.5 - 5.3 g/dL, MA is \\<0.9\\* LLN, or if BL\\<LLN then use \\<0.75 BL","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"2.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"1.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.76","spread":"1.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.21","spread":"3.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.44","spread":"5.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.35","spread":"2.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.60","spread":"3.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.13","spread":"2.34"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Change From Baseline in Bilirubin, Blood Urea Nitrogen (BUN), Creatinine, Calcium (Ca), Phosphorus (P), Serum Glucose (Glu), and Uric Acid Over Time","description":"Bilirubin NR=0.2-1.2 mg/dL, MA: \\>2\\* ULN, or if BL\\>ULN then use \\>4\\* BL. BUN NR=4.0-24.0 mg/dL, MA: \\>2\\*BL. Creatinine NR=0.4-1.2 mg/dL, MA: \\>1.5\\*BL. Ca NR=8.8-10.2 mg/dL, MA: \\<0.8\\*LLN/\\>1.2\\*ULN, or if BL\\<LLN then use 0.75\\*BL or \\>ULN, or if BL\\>ULN then use\\>1.25\\*BL or \\<LLN. P NR=2.8-4.0 mg/dL, MA: \\<0.75\\*LLN/ \\>1.25\\*ULN, or if BL\\<LLN then use 0.67\\*BL or \\>ULN, or if BL\\>ULN then use\\>1.33\\*BL or \\<LLN. Glu MA: \\<65 mg/dL/ \\>220 mg/dL. Uric acid MA: \\>1.5\\*ULN, or if BL\\>ULN then use \\>2\\*BL.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.85","spread":"0.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.11","spread":"0.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.13","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":"2.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.18","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.07","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.77","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.71","spread":"2.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.11","spread":"0.11"}]}]}]},{"type":"PRIMARY","title":"LT; Change From Baseline in Sodium (Na), Potassium (K), Chloride (Cl) Over Time","description":"Na NR=132 - 147 mEq/L, MA is 95\\* LLN/ \\>1.05\\* ULN, or if BL\\<LLN then use 0.95\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.05\\* BL or \\<LLN. K NR=3.3 - 5.5 mEq/L, MA is \\<0.9\\* LLN/\\>1.1\\* ULN,or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN. Cl NR=94 - 111 mEq/L, MA is \\<0.9\\* LLN/\\>1.1\\* ULN, or if BL\\<LLN then use 0.9\\* BL or \\>ULN, or if BL\\>ULN then use\\>1.1\\* BL or \\<LLN","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.91","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.08","spread":"0.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.37","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.23","spread":"0.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.06","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.42","spread":"0.37"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Mean Sitting Systolic Blood Pressure (SBP) Over Time","description":"Measurements were taken in a seated position before and after abatacept infusion.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"125.1","spread":"16.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.3","spread":"16.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.4","spread":"16.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.9","spread":"16.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.9","spread":"16.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.4","spread":"16.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.0","spread":"17.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.9","spread":"16.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.2","spread":"17.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.8","spread":"16.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.1","spread":"18.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.8","spread":"17.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.8","spread":"16.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.0","spread":"18.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"126.2","spread":"17.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.0","spread":"15.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.0","spread":"18.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.1","spread":"17.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.5","spread":"19.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.4","spread":"15.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.8","spread":"18.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.0","spread":"17.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.3","spread":"19.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.9","spread":"16.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"124.3","spread":"20.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.7","spread":"17.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.4","spread":"16.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.2","spread":"17.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.6","spread":"18.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120.6","spread":"18.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.6","spread":"15.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.1","spread":"18.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.1","spread":"15.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.3","spread":"18.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120.0","spread":"18.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.8","spread":"18.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.4","spread":"18.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.6","spread":"17.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.4","spread":"16.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117.6","spread":"15.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.5","spread":"21.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.9","spread":"17.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"121.1","spread":"16.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.3","spread":"19.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.1","spread":"19.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117.3","spread":"18.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.4","spread":"12.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.0","spread":"14.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115.3","spread":"15.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.1","spread":"18.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117.6","spread":"14.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"117.6","spread":"14.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.4","spread":"14.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115.4","spread":"12.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.4","spread":"16.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.2","spread":"18.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.8","spread":"15.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.5","spread":"20.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115.6","spread":"16.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.4","spread":"18.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.8","spread":"20.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.9","spread":"13.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113.5","spread":"16.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115.3","spread":"15.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.1","spread":"24.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"119.4","spread":"16.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.5","spread":"18.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"113.5","spread":"14.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"118.3","spread":"20.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"115.1","spread":"11.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.9","spread":"13.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"116.4","spread":"8.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"114.6","spread":"12.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"114.6","spread":"7.72"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Mean Sitting Diastolic Blood Pressure (DBP) Over Time","description":"Measurements were taken in a seated position before and after abatacept infusion.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"10.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.9","spread":"9.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.0","spread":"10.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.4","spread":"10.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":"10.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.7","spread":"9.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.5","spread":"10.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.5","spread":"10.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.7","spread":"10.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.3","spread":"9.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.4","spread":"10.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.6","spread":"10.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.5","spread":"10.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.5","spread":"10.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.4","spread":"10.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":"10.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.3","spread":"12.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.7","spread":"10.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.1","spread":"11.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.5","spread":"10.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.8","spread":"10.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.6","spread":"11.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.4","spread":"13.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.2","spread":"11.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.3","spread":"12.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.9","spread":"13.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.6","spread":"11.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.0","spread":"11.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.9","spread":"12.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2","spread":"12.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.8","spread":"12.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.7","spread":"11.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.4","spread":"10.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.7","spread":"12.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"10.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.2","spread":"11.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.3","spread":"10.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"10.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.0","spread":"9.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.3","spread":"8.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.7","spread":"11.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.8","spread":"10.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":"9.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"10.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.5","spread":"10.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.7","spread":"9.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.2","spread":"8.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":"10.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"8.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2","spread":"10.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.7","spread":"10.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.1","spread":"9.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.8","spread":"7.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.9","spread":"7.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.5","spread":"9.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.8","spread":"10.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.7","spread":"10.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.5","spread":"10.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.7","spread":"11.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.7","spread":"11.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.6","spread":"9.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.3","spread":"9.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.3","spread":"11.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.2","spread":"8.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.5","spread":"7.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"7.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.8","spread":"6.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.3","spread":"5.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"5.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.6","spread":"4.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.6","spread":"4.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"3.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.1","spread":"9.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.4","spread":"7.35"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Mean Heart Rate (HR) Over Time","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"74.4","spread":"11.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.0","spread":"10.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.4","spread":"11.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.8","spread":"10.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.7","spread":"10.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.5","spread":"9.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":"11.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.1","spread":"10.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"11.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"10.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":"9.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.0","spread":"9.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.1","spread":"11.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.9","spread":"8.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.7","spread":"12.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.1","spread":"10.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.0","spread":"10.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"9.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.2","spread":"10.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.6","spread":"8.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.2","spread":"10.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.7","spread":"9.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.4","spread":"12.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.9","spread":"10.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"11.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.0","spread":"8.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2","spread":"11.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.7","spread":"12.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"10.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.3","spread":"10.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.0","spread":"9.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.5","spread":"9.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.9","spread":"10.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.7","spread":"9.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.6","spread":"13.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.1","spread":"13.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.5","spread":"11.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.3","spread":"10.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.1","spread":"12.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.3","spread":"10.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.7","spread":"11.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.7","spread":"11.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.1","spread":"9.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.2","spread":"9.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.5","spread":"8.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.4","spread":"8.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":"11.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.4","spread":"10.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.2","spread":"10.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.4","spread":"9.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"12.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.3","spread":"11.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.7","spread":"9.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.9","spread":"9.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.7","spread":"7.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.0","spread":"7.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.5","spread":"10.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.8","spread":"7.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.7","spread":"13.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.8","spread":"8.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.1","spread":"10.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.6","spread":"7.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.6","spread":"11.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"10.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.3","spread":"8.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"9.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.6","spread":"9.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.3","spread":"8.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"4.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.1","spread":"3.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.0","spread":"1.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.9","spread":"4.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":"8.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.1","spread":"10.71"}]}]}]},{"type":"PRIMARY","title":"Long-term Period: Mean Temperature (T) Over Time","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.6","spread":"0.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.5","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.0","spread":"0.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.0","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.4","spread":"0.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.3","spread":"0.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.1","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.2","spread":"0.38"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Change From Baseline to Day 169 in SF-36 PCS, MCS, and SF-36 Individual Component Scores","description":"The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score. Change from Baseline= post-Baseline - Baseline value.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.50","spread":"0.44"},{"groupId":"OG001","value":"6.08","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.79","spread":"0.59"},{"groupId":"OG001","value":"5.43","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.31","spread":"0.52"},{"groupId":"OG001","value":"4.66","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.85","spread":"0.59"},{"groupId":"OG001","value":"6.82","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.20","spread":"0.45"},{"groupId":"OG001","value":"8.72","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.85","spread":"0.38"},{"groupId":"OG001","value":"3.83","spread":"0.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.32","spread":"0.51"},{"groupId":"OG001","value":"6.37","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.44","spread":"0.58"},{"groupId":"OG001","value":"7.18","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.30","spread":"0.76"},{"groupId":"OG001","value":"5.85","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.74","spread":"0.52"},{"groupId":"OG001","value":"4.41","spread":"0.46"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Baseline Fatigue Visual Analog Scale (VAS)","description":"The VAS for Fatigue (VAS-F) consists of a 100 mm line, with 0 (No Fatigue) on 1 end and 100 (Extreme Fatigue) on the other end, which a participant marks to indicate how much fatigue he or she feels. The marked point in mm is converted into a numeric value from 0 to 100, where 0=no fatigue and 100=maximum fatigue. Increasing numbers=increasing fatigue.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73.33","spread":"19.67"},{"groupId":"OG001","value":"72.70","spread":"20.75"}]}]}]},{"type":"SECONDARY","title":"Short-term Period: Mean Change From Baseline to Day 169 in Fatigue Visual Analog Scale (VAS)","description":"The VAS for Fatigue (VAS-F) consists of a 100 mm line, with 0 (No Fatigue) on 1 end and 100 (Extreme Fatigue) on the other end, which a participant marks to indicate how much fatigue he or she feels. The marked point in mm is converted into a numeric value from 0 to 100, where 0=no fatigue and 100=maximum fatigue. Increasing numbers=increasing fatigue.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.3","spread":"1.35"},{"groupId":"OG001","value":"-20.2","spread":"1.25"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Number of Participants With Clinically Meaningful Improvement in DAS 28, Low Disease Activity, or Remission Over Time","description":"The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). A clinically significant response= decrease in DAS28 score of \\>1.2 from baseline.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"163","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) DAS 28 and DAS 28 for Post-Baseline Visits Over the Long Term","description":"The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). Time-matched baseline (Day 0)values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.18","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.90","spread":"1.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.16","spread":"0.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.55","spread":"1.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.16","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.52","spread":"1.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.15","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.44","spread":"1.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.16","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.49","spread":"1.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.26","spread":"0.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.28","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in DAS 28 Over The Long Term","description":"The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or CRP, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (\\> 5.1), low disease activity (\\< 3.2) and remission (\\< 2.6). Time-matched mean change from BL= Post-BL value - time-matched BL value, where the time-matched BL value represents the mean BL(Day 0)value for only that cohort of participants with measurements available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.28","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.62","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.64","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.72","spread":"0.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.66","spread":"0.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.97","spread":"0.22"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) Number of Tender Joints and Number of Tender Joints for Post-Baseline Visits Over the Long Term","description":"The mean number of tender joints was evaluated based on the number of tender joints in a standard 68 joint count. Time-matched baseline (Day 0) values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.90","spread":"5.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.04","spread":"6.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.57","spread":"5.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.39","spread":"5.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.14","spread":"5.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.34","spread":"4.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.29","spread":"5.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"4.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.40","spread":"5.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.02","spread":"5.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.42","spread":"5.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.67","spread":"4.04"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in Number of Tender Joints Over the Long Term","description":"The mean number of tender joints was evaluated based on the number of tender joints in a standard 68 joint count. Time-matched mean change from baseline = Post-baseline value - time-matched baseline value, where the time-matched baseline value represents the mean baseline (Day 0) value for only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.9","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.2","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.8","spread":"0.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.5","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.4","spread":"0.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.7","spread":"1.12"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) Number of Swollen Joints And Post-Baseline Number of Swollen Joints Over the Long Term","description":"The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 66 joint count. Time-matched baseline (Day 0) values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.72","spread":"5.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.56","spread":"4.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.50","spread":"4.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.63","spread":"3.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.91","spread":"5.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.81","spread":"2.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.98","spread":"4.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.97","spread":"3.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.57","spread":"4.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.02","spread":"4.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.40","spread":"4.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.14","spread":"3.10"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-Matched Change From Baseline (Day 0) in Number of Swollen Joints Over the Long Term","description":"The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 66 joint count. Time-matched mean change from baseline = Post-baseline value - time-matched baseline value, where the time-matched baseline value represents the mean baseline (Day 0) value for only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.16","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.87","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.09","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.01","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.56","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.3","spread":"0.76"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) Hs-CRP Levels and Hs-CRP Levels for Post-Baseline Over the Long Term","description":"hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28. Time-matched baseline (Day 0) values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.36","spread":"2.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.24","spread":"1.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.48","spread":"2.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.97","spread":"1.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.65","spread":"2.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.93","spread":"1.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.82","spread":"3.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"1.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.47","spread":"3.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":"1.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.60","spread":"2.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":"0.96"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in Hs-CRP Level Over the Long Term","description":"hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28. Time-matched mean change from baseline = Post-baseline value - time-matched baseline value, where the time-matched baseline value represents the mean baseline (Day 0) value for only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.12","spread":"0.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.51","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.72","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.02","spread":"0.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.49","spread":"0.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.92","spread":"0.43"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) Visual Analog Scale (VAS) and VAS for Post-Baseline Visits Over the Long Term","description":"The VAS for Fatigue (VAS-F) consists of a 100 mm line, with 0 (No Fatigue) on 1 end and 100 (Extreme Fatigue) on the other end, which a participant marks to indicate how much fatigue he or she feels. The marked point in mm is converted into a numeric value from 0 to 100, where 0=no fatigue and 100=maximum fatigue. Increasing numbers=increasing fatigue. Time-matched baseline (Day 0) values and post-baseline values were presented for each post-baseline visit, and represent only that cohort of participants with measurements available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"74.05","spread":"16.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.61","spread":"24.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.20","spread":"15.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.74","spread":"24.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.41","spread":"15.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.27","spread":"23.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.59","spread":"14.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.16","spread":"22.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.48","spread":"16.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.90","spread":"23.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74.47","spread":"16.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.61","spread":"22.13"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in VAS Over the Long Term","description":"The VAS for Fatigue (VAS-F) consists of a 100 mm line, with 0 (No Fatigue) on 1 end and 100 (Extreme Fatigue) on the other end, which a participant marks to indicate how much fatigue he or she feels. The marked point in mm is converted into a numeric value from 0 to 100, where 0=no fatigue and 100=maximum fatigue. Increasing numbers=increasing fatigue. Time-matched mean change from BL = Post-BL value - time-matched BL value, where the time-matched BL value represents the mean BL (Day 0) value for only that cohort of participants with data available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-33.4","spread":"1.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.5","spread":"2.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.1","spread":"2.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.4","spread":"2.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.6","spread":"3.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.9","spread":"4.03"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) HAQ-DI and HAQ-DI Component Scores For Participant Cohorts at Each Corresponding Post-baseline Visit Over the Long Term","description":"HAQ-DI includes 20 questions to assess physical functions in 8 domains:dressing, arising,eating,walking, hygiene, reach, grip and common activities. Domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. HAQ-DI= sum of worst scores in each domain divided by number of domains answered. HAQ-DI minimum=0 (no difficulty), max overall score=3(unable to do). Time-matched BL(Day 0)values presented for each post-BL visit represent only that cohort of participants with measurements available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.80","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.62","spread":"0.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.39","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.84","spread":"0.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.43","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.08","spread":"0.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.12","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.94","spread":"0.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.89","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.45","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.01","spread":"0.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.53","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.11","spread":"0.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.23","spread":"0.77"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.97","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.05","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.87","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.78","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.41","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.96","spread":"0.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.07","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.22","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.96","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.03","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.86","spread":"0.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.78","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.94","spread":"0.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.54","spread":"0.72"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.02","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.20","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.94","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.04","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.86","spread":"0.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.75","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.95","spread":"0.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"0.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.24","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.90","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.03","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.01","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.92","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.59","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.18","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.69","spread":"0.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.10","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.41","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.18","spread":"0.79"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean HAQ-DI and HAQ-DI Component Scores For Participant Cohorts at Post-baseline Visits Over the Long Term","description":"HAQ-DI includes 20 questions to assess physical functions in 8 domains:dressing, arising, eating, walking, hygiene, reach, grip and common activities. Domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1=with some difficulty, 2=with much difficulty, and 3=unable to do. HAQ-DI= sum of worst scores in each domain divided by number of domains answered. HAQ-DI minimum=0(no difficulty), max overall score=3(unable to do). Post-BL values presented for each visit represent only that cohort of participants with measurements available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.34","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":"0.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.85","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.26","spread":"1.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.03","spread":"0.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.70","spread":"1.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.73","spread":"1.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.45","spread":"0.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.52","spread":"1.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.37","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.17","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.35","spread":"1.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.02","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.67","spread":"1.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.79","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","spread":"0.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.61","spread":"1.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":"0.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.30","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":"0.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"1.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.81","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.48","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.58","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.27","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.73","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.96","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.48","spread":"0.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.70","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.43","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"0.93"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.34","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.03","spread":"0.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.11","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.48","spread":"1.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.73","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.57","spread":"0.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.68","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.38","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.18","spread":"0.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.46","spread":"0.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.10","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.59","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.36","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"0.93"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in HAQ-DI and HAQ-DI Components For Participant Cohorts at Each Corresponding Post-baseline Visit Over the Long Term","description":"HAQ-DI includes 20 questions assessing physical functions in 8 domains:dressing,arising,eating,walking,hygiene,reach,grip and common activities.Domain questions evaluated on 4-point scale: 0=without any difficulty,1=with some difficulty,2=with much difficulty,and 3=unable to do. HAQ-DI=sum of worst scores in each domain ÷ number of domains answered. HAQ-DI minimum=0 (no difficulty), max overall score=3(unable to do). Time-matched mean change from BL= Post-BL value - time-matched BL value. Time-matched BL value=mean BL (Day 0)value for only that cohort with data available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.46","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.54","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.58","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.39","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.38","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.38","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.49","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.52","spread":"0.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.60","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.52","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.54","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.64","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.58","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.50","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.41","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.49","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.45","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.81","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.66","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.61","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.58","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.54","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.71","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.62","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.46","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.52","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.35","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.63","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.74","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.77","spread":"0.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.72","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.59","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.69","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.64","spread":"0.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.41","spread":"0.13"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Number of Participants Achieving Clinically Meaningful HAQ Response Over Time","description":"HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do). Clinically meaningful HAQ response=an improvement of at least 0.3 units from baseline in HAQ disability Index.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Baseline (Day 0) SF-36 PCS, MCS, and SF-36 Individual Component Scores For Participant Cohorts at Each Corresponding Post-baseline Visit Over the Long Term","description":"SF-36 has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary=physical functioning, role-physical, bodily pain, and general health;(2) mental component summary=vitality,social functioning,role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score and 100=best score. Time-matched BL (Day 0) values presented for each post-BL visit represent only that cohort of participants with measurements available at that post-BL visit","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.96","spread":"7.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.09","spread":"12.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.04","spread":"9.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.17","spread":"7.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.07","spread":"7.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.04","spread":"9.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.96","spread":"9.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.31","spread":"11.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.80","spread":"13.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.89","spread":"12.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.76","spread":"6.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.06","spread":"13.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.66","spread":"9.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.87","spread":"6.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.35","spread":"7.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.23","spread":"9.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.77","spread":"9.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"32.59","spread":"12.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.30","spread":"11.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.67","spread":"13.17"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean SF-36 PCS, MCS, and SF-36 Individual Component Scores For Participant Cohorts at Each Post-baseline Visits Over the Long Term","description":"SF-36 measures health-related quality of life and has 36 questions with 8 subscale scores and 2 summary scores (1)physical component summary=physical functioning,role-physical,bodily pain,and general health; (2)mental component summary=vitality,social functioning,role-emotional,and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0=worst score and 100=best score. Post-BL values presented for each post-BL visit represent only that cohort of participants with measurements available at that post-BL visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.00","spread":"10.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.15","spread":"12.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.33","spread":"11.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.85","spread":"11.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.78","spread":"9.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.58","spread":"10.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.82","spread":"11.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.24","spread":"11.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.63","spread":"14.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"45.00","spread":"12.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.92","spread":"9.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.06","spread":"12.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.91","spread":"11.15"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.61","spread":"11.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.89","spread":"10.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.99","spread":"9.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.94","spread":"10.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.28","spread":"11.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37.37","spread":"14.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.02","spread":"11.80"}]}]}]},{"type":"SECONDARY","title":"Long-term Period: Mean Time-matched Change From Baseline (Day 0) in SF-36 PCS, MCS, and SF-36 Individual Component Scores For Participant Cohorts at Each Corresponding Post-baseline Visit Over the Long Term","description":"SF-36 has 36 questions with 8 subscale scores and 2 summary scores (1)physical component summary=physical functioning,role-physical,bodily pain,and general health; (2)mental component summary=vitality,social functioning,role-emotional,and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0=worst score and 100=best score. Time-matched mean change from BL= Post-BL value - time-matched BL value. Time-matched BL value=mean BL (Day 0)value for only that cohort with data available at that post-baseline visit.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.04","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.06","spread":"0.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.29","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.69","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.70","spread":"0.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.54","spread":"0.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.86","spread":"0.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.93","spread":"0.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.83","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.11","spread":"0.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.17","spread":"1.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.99","spread":"1.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.25","spread":"1.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.74","spread":"1.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.54","spread":"1.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.76","spread":"0.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.16","spread":"1.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.69","spread":"1.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.06","spread":"1.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.35","spread":"1.16"}]}]}]},{"type":"SECONDARY","title":"LT; Number of Participants With Positive Anti-Abatacept or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Responses by ELISA","description":"Serum samples from all treated adult participants with active rheumatoid arthritis (RA) were screened for the presence of drug-specific antibodies using ELISA. Immunogenicity was defined as the presence of a positive anti-abatacept or anti-CTLA4 antibody.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":61,"n":530},"commonTop":["HEADACHE","NAUSEA","UPPER RESPIRATORY TRACT INFECTION","SINUSITIS","DIARRHOEA"]}}}